Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | +5.60% |
|
-27.87% | -64.23% |
Jun. 21 | Top Premarket Gainers | MT |
Jun. 13 | Barclays Adjusts Price Target on Barinthus Biotherapeutics to $3 From $7, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.23% | 48.79M | |
+34.14% | 51.51B | |
-6.54% | 39.03B | |
+34.92% | 38.91B | |
-12.11% | 26.68B | |
+12.62% | 26.13B | |
-13.43% | 19.91B | |
+43.73% | 13.71B | |
+31.81% | 12.38B | |
-4.54% | 11.74B |
- Stock Market
- Equities
- BRNS Stock
- News Barinthus Biotherapeutics plc
- Vaccitech Promotes Gemma Brown as Finance Chief